At this point in the company development AELA achieved a remarkable success with integration of Zentaris and practically guaranteed a big milestone payment coming from Solvay. The most prudent use of this massive cash pile would be to go shopping. While Atrium is flexing muscles acquiring more companies every quarter or so before an eventual IPO, AELA could surprise us with a nice biotech acquisition on its own, bolstering the pipeline to some 15-20 drugs :-) and, possibly, getting a major US coverage while doing so.
Thanks for the info you keep providing, you give me hope that investing still actually works.
I was wondering what your opinion is on profitwaves.com, which I saw you referenced in here. I did the trial for like 3 weeks, and results have been spotty due to the current crappy market conditions. The author seems very well informed and intelligent, but I was just wondering about the bottom line, which is of course $$$ (positive % preferred). Any insight would be great.
I used their service for 6 months and I value Profitwaves highly. They provide very intelligent and unbiased view of the market and even if they don't recommend to buy or sell anything due to the difficult market conditions, their analysis is well worth the money. I had several good trades by following their advice/screens. Some of them turned to be very successful, some not so successful (but mostly because of my fault). Since they back their recommendations by buying the recommended stocks it's hard to loose if you are patient and disciplined, the qualities which Profitwaves teach by example.